Search Results - Axel Finckh

Refine Results
  1. 1
    Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis

    Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis by Axel Finckh

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    The impact of obesity on the development and progression of rheumatoid arthritis

    The impact of obesity on the development and progression of rheumatoid arthritis by Axel Finckh, Carl Turesson

    Published 2014
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  3. 3
    Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

    Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review by Andrea Rubbert‐Roth, Axel Finckh

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study

    The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study by Axel Finckh, Silvia Dehler, Cem Gabay

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment

    Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment by Axel Finckh, Hyon K. Choi, Frederick Wolfe

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study

    The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study by Diego Kyburz, Cem Gabay, BA Michel, Axel Finckh

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry

    Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry by Cem Gabay, Myriam Riek, Almut Scherer, Axel Finckh

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Cigarette smoking and radiographic progression in rheumatoid arthritis

    Cigarette smoking and radiographic progression in rheumatoid arthritis by Axel Finckh, Silvia Dehler, Karen H. Costenbader, Cem Gabay

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis

    Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network... by Felicity Buckley, Axel Finckh, T. Huizinga, F. Dejonckheere, Jeroen P. Jansen

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis

    Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis by Kim Lauper, Delphine S. Courvoisier, Paola Chevallier, Axel Finckh, Cem Gabay

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study

    Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study by Burkhard Möller, Almut Scherer, Frauke Förger, Peter M. Villiger, Axel Finckh

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    The role of female hormonal factors in the development of rheumatoid arthritis

    The role of female hormonal factors in the development of rheumatoid arthritis by D. Alpizar-Rodriguez, Nicola Pluchino, G. Canny, Cem Gabay, Axel Finckh

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease

    Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease by Saskia Ditisheim, Nicolas Fournier, Pascal Juillerat, Valérie Pittet, Pierre Michetti, Cem Gabay, Axel Finckh

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort

    Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort by R Mueller, T. Kaegi, Axel Finckh, Sarah R. Haile, Hendrik Schulze‐Koops, J. von Kempis

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis

    Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis by Sophie Martin Du Pan, Silvia Dehler, Adrian Ciurea, Hans‐Rudolf Ziswiler, Cem Gabay, Axel Finckh

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Do synovial leptin levels correlate with pain in end stage arthritis?

    Do synovial leptin levels correlate with pain in end stage arthritis? by Anne Lübbeke, Axel Finckh, Gábor J. Puskás, Domizio Suvà, Alexandre Lädermann, Sylvette Bas, Daniel Fritschy, Cem Gabay, Pierre Hoffmeyer

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

    Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an a... by Axel Finckh, Adrian Ciurea, Laure Brulhart, Burkhard Möller, Ulrich A. Walker, D. Courvoisier, Diego Kyburz, Jean Dudler, Cem Gabay

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women

    Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women by Axel Finckh, Glinda S. Cooper, Lori B. Chibnik, Karen H. Costenbader, Julie Watts, Helen Pankey, Patricia A. Fraser, Elizabeth W. Karlson

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    <i>Prevotella copri</i> in individuals at risk for rheumatoid arthritis

    <i>Prevotella copri</i> in individuals at risk for rheumatoid arthritis by D. Alpizar-Rodriguez, Till Robin Lesker, Achim Gronow, Benoît Gilbert, Elena Raemy, Céline Lamacchia, Cem Gabay, Axel Finckh, Till Strowig

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

    Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis by Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia, Laura Martinez Prat, Michael Mähler, Chelsea Bentow, Axel Finckh, Cem Gabay, Michael J. Nissen

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: